Invesco
OMED

Invesco’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Invesco’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-217
Closed -$5K – 4307
2015
Q2 		$5K Buy
+217
New +$5.35K ﹤0.01% 4270
2014
Q3 		– Sell
-38,317
Closed -$892K – 4187
2014
Q2 		$892K Buy
+38,317
New +$946K ﹤0.01% 3077

Other funds holding OMED

ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco's OMED Position: Q3 2015 in Review

Invesco sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q3 2015, closing a stake of 217 shares — an estimated $5K sold.

Invesco first reported a position in OMED in Q2 2014 and held it in 2 quarters. The position peaked at $892K in Q2 2014. 87 funds tracked by Wall St. Rank hold OMED as of Q3 2015.

  • Invesco reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Invesco sold 217 OncoMed Pharmaceuticals, Inc. shares in Q3 2015, an estimated $5K.
  • Invesco first reported a position in OncoMed Pharmaceuticals, Inc. in Q2 2014 and held it in 2 quarters.
  • Invesco's OncoMed Pharmaceuticals, Inc. position peaked at $892K in Q2 2014.
  • 87 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q3 2015.

Based on Invesco's 13F filing for Q3 2015, filed 16 Nov 2015.